VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $826,000 | -2.7% | 285,319 | +125.3% | 0.00% | – |
| Q3 2021 | $849,000 | -5.2% | 126,642 | -11.9% | 0.00% | – |
| Q2 2021 | $896,000 | +52.6% | 143,707 | +50.5% | 0.00% | – |
| Q1 2021 | $587,000 | -34.0% | 95,504 | -27.9% | 0.00% | -100.0% |
| Q4 2020 | $889,000 | +20.3% | 132,496 | +5.2% | 0.00% | 0.0% |
| Q3 2020 | $739,000 | -24.2% | 125,947 | -11.1% | 0.00% | 0.0% |
| Q2 2020 | $975,000 | +69.6% | 141,690 | +10.6% | 0.00% | 0.0% |
| Q1 2020 | $575,000 | -84.2% | 128,053 | -71.8% | 0.00% | -50.0% |
| Q4 2019 | $3,642,000 | +326.5% | 454,140 | +266.0% | 0.00% | – |
| Q3 2019 | $854,000 | -15.3% | 124,095 | +2.2% | 0.00% | – |
| Q2 2019 | $1,008,000 | -6.5% | 121,407 | +11.9% | 0.00% | -100.0% |
| Q1 2019 | $1,078,000 | +69.5% | 108,539 | +30.9% | 0.00% | – |
| Q4 2018 | $636,000 | -17.5% | 82,939 | +87.5% | 0.00% | -100.0% |
| Q3 2018 | $771,000 | +32.9% | 44,243 | -27.6% | 0.00% | – |
| Q2 2018 | $580,000 | – | 61,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |